BGF World Healthscience vs Aktiespararna Direktavkastning A

BGF World Healthscience vs Aktiespararna Direktavkastning A

1. BGF World Healthscience

  • Security

    BGF World Healthscience A2

  • Fee

    2.17%

  • ISIN

    LU0122379950

  • Holdings

    10

2. Aktiespararna Direktavkastning A

  • Security

    Aktiespararna Direktavkastning A

  • Fee

    0.30%

  • ISIN

    SE0008321780

  • Holdings

    26

Fund Holdings

We have information about 20 holdings in BGF World Healthscience, where the largest holding is UnitedHealth (8.2), followed by Eli Lilly (7.01) and Novo Nordisk (6.67). In comparison with Aktiespararna Direktavkastning A, we have 36 holdings where Axfood is the largest holding (5.69), followed by Tele2 (5.43) and Avanza (5.17).

All Holdings

Here we compare the holdings in BGF World Healthscience and Aktiespararna Direktavkastning A.

BGF World Healthscience Aktiespararna Direktavkastning A
1. UnitedHealth Group Inc
USA
8.2 %
1. Axfood AB
Sweden
5.69 %
2. Eli Lilly and Co
USA
7.01 %
2. Tele2 B
Sweden
5.43 %
3. Novo Nordisk B
Denmark
6.67 %
3. Avanza Bank Holding
Sweden
5.17 %
4. Merck & Co Inc
Germany
3.99 %
4. Telia Company AB
Sweden
5.05 %
5. Boston Scientific Corp
3.67 %
5. Swedbank A
Sweden
4.93 %
6. AbbVie Inc
USA
3.61 %
6. Autoliv SDB
Sweden
4.91 %
7. Amgen Inc
3.58 %
7. Nordea Bank Abp
Finland
4.83 %
8. Sanofi SA
France
3.05 %
8. Stora Enso R
Finland
4.8 %
9. Abbott Laboratories
USA
3.02 %
9. Hennes & Mauritz B
Sweden
4.72 %
10. AstraZeneca
Sweden UK
2.98 %
10. Handelsbanken A
Sweden
4.65 %
- 11. Ericsson B
Sweden
4.57 %
- 12. SKF B
Sweden
4.57 %
- 13. Holmen B
Sweden
4.55 %
- 14. SEB A
Sweden
4.53 %
- 15. Securitas B
Sweden
4.48 %
- 16. Skanska B
Sweden
4.45 %
- 17. Husqvarna B
Sweden
4.44 %
- 18. Essity B
Sweden
4.38 %
- 19. SSAB B
Sweden
4.27 %
- 20. Billerud AB
Sweden
4.22 %
- 21. Elekta B
Sweden
4.16 %
- 22. Volvo B
Sweden
3.98 %
- 23. JM
3.65 %
- 24. Boliden AB
Sweden
3.43 %
- 25. Intrum AB
2.14 %
- 26. SBB B
1.2 %

The list of fund holdings was last updated on June 5, 2025.